mmu-miR-185通过向Btk来调节骨质细胞的分化和迁移
Dan He1, Yueying Jiao1, Jian Xu2
1Department of Medical Genetics, Peking University School of Basic Medical Sciences, Beijing, China.
The journal of gene medicine
|May 1, 2024
概括
微RNA-185-5p (miR-185-5p) 抑制骨质细胞分化和迁移. 这种微RNA通过准布鲁顿的氨酸激酶 (Btk) 来调节骨重塑.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 骨生物学 骨生物学 骨生物学
背景情况:
- 骨重塑涉及结合的骨质细胞和骨质细胞活动.
- 之前,miR-185的耗尽与骨形成的增强有关.
- miR-185-5p在骨质细胞形成中的作用尚不清楚.
研究的目的:
- 研究miR-185-5p在骨质细胞分化和迁移中的作用.
- 在骨质细胞功能背景下确定miR-185-5p的下游目标.
主要方法:
- 在miR-185基因淘汰和野生型小鼠中使用耐酸酸酶染色评估骨质细胞分化.
- 通过RT-qPCR进行量化miR-185-5p和骨质细胞标记基因表达 (Trap,Dcstamp,Ctsk,Nfatc1).
- 利用西方斑块,细胞计数套件-8,Transwell测定和双化酶记者测定来分析细胞行为和向相互作用.
主要成果:
- miR-185的耗尽增强了骨髓衍生的单细胞/巨细胞的骨质细胞分化.
- 过度表达miR-185-5p抑制了RAW264.7细胞中的骨质细胞分化和迁移.
- 布鲁顿的氨酸激酶 (Btk) 被证实是miR-185-5p的直接下游标.
结论:
- miR-185-5p在骨质细胞分化和迁移中起着调节作用.
- 过度表达miR-185-5p可以在体外抑制骨质结晶发生.
- miR-185-5p调节骨质细胞活动,可能通过调节Btk表达.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
TGF - β Signaling Pathway
7.3K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.3K


